Sandoz Group

Profilo dell'azienda

Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company has a strategic collaboration with Shanghai Henlius Biotech, Inc. to broaden patient access to biosimilar medicines. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.

Descrizione disponibile in inglese.

Dati societari

Settore

Salute

Industria

Drug Manufacturers - Specialty & Generic

Paese

Svizzera

Sede

Centralbahnstrasse 4, 4051, Basel

Dipendenti

20.000

Quotazione

SDZ · SIX

Indici

SMI

Valuta

CHF

ISIN

CH1243598427

Sito web

sandoz.com